Please assess the completion status of the following clinical trial:

Trial Title: Identification and Treatment of Clinically Silent Catheter-Related Deep Vein Thrombosis in Children With Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Diagnosis of cancer~2. Age ≤ 18 years~3. First tunneled central venous catheter (implanted port or external) inserted in the upper venous system (subclavian, brachiocephalic, or jugular vein) within the previous 2 weeks~4. Catheter expected to be in place for duration of chemotherapy (≥ 3 months)~5. History of no more than one catheter complication (occlusion or infection)~Exclusion Criteria:~1. Prior history of DVT~2. Currently receiving an anticoagulant or anti-platelet agents on a daily basis~3. Diagnosis of high grade malignant brain tumor or metastasis to the brain~4. Clinical signs/symptoms of DVT~5. Clinical signs/symptoms of Pulmonary embolism~6. Renal failure~7. Recent major hemorrhage

- Gender: ALL
- Minimum Age: None
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- A-randomized to treatment (Type: EXPERIMENTAL): Patients diagnosed with asymptomatic catheter-related DVT who are randomized to treatment with enoxaparin for 6 weeks
- B-randomized to close (Type: NO_INTERVENTION): Patients diagnosed with asymptomatic catheter-related DVT who are randomized to close observation for 6 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).